Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
2004 2
2006 1
2008 1
2010 2
2011 3
2012 6
2013 4
2014 3
2015 2
2016 2
2017 3
2018 4
2020 2
2021 4
2022 4
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

41 results
Results by year
Filters applied: . Clear all
Page 1
Treatment optimization in multiple sclerosis.
Freedman MS, Patry DG, Grand'Maison F, Myles ML, Paty DW, Selchen DH; Canadian MS Working Group. Freedman MS, et al. Among authors: selchen dh. Can J Neurol Sci. 2004 May;31(2):157-68. doi: 10.1017/s0317167100053804. Can J Neurol Sci. 2004. PMID: 15198439 Review.
Bilateral medial medullary infarction: a systematic review.
Pongmoragot J, Parthasarathy S, Selchen D, Saposnik G. Pongmoragot J, et al. Among authors: selchen d. J Stroke Cerebrovasc Dis. 2013 Aug;22(6):775-80. doi: 10.1016/j.jstrokecerebrovasdis.2012.03.010. Epub 2012 Apr 26. J Stroke Cerebrovasc Dis. 2013. PMID: 22541608 Review.
Expert opinion on the use of cladribine tablets in clinical practice.
Sørensen PS, Centonze D, Giovannoni G, Montalban X, Selchen D, Vermersch P, Wiendl H, Yamout B, Salloukh H, Rieckmann P. Sørensen PS, et al. Among authors: selchen d. Ther Adv Neurol Disord. 2020 Jun 24;13:1756286420935019. doi: 10.1177/1756286420935019. eCollection 2020. Ther Adv Neurol Disord. 2020. PMID: 32636933 Free PMC article. Review.
Good is not Good Enough: The Benchmark Stroke Door-to-Needle Time Should be 30 Minutes.
Kamal N, Benavente O, Boyle K, Buck B, Butcher K, Casaubon LK, Côté R, Demchuk AM, Deschaintre Y, Dowlatshahi D, Gubitz GJ, Hunter G, Jeerakathil T, Jin A, Lang E, Lanthier S, Lindsay P, Newcommon N, Mandzia J, Norris CM, Oczkowski W, Odier C, Phillips S, Poppe AY, Saposnik G, Selchen D, Shuaib A, Silver F, Smith EE, Stotts G, Suddes M, Swartz RH, Teal P, Watson T, Hill MD. Kamal N, et al. Among authors: selchen d. Can J Neurol Sci. 2014 Nov;41(6):694-6. doi: 10.1017/cjn.2014.41. Epub 2014 Oct 20. Can J Neurol Sci. 2014. PMID: 25376123 Review. No abstract available.
Treatment optimization in MS: Canadian MS Working Group updated recommendations.
Freedman MS, Selchen D, Arnold DL, Prat A, Banwell B, Yeung M, Morgenthau D, Lapierre Y; Canadian Multiple Sclerosis Working Group. Freedman MS, et al. Among authors: selchen d. Can J Neurol Sci. 2013 May;40(3):307-23. doi: 10.1017/s0317167100014244. Can J Neurol Sci. 2013. PMID: 23603165 Review.
Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice.
Rieckmann P, Centonze D, Giovannoni G, Hua LH, Oreja-Guevara C, Selchen D, Sørensen PS, Vermersch P, Wiendl H, Salloukh H, Yamout B. Rieckmann P, et al. Among authors: selchen d. Ther Adv Neurol Disord. 2021 Dec 7;14:17562864211058298. doi: 10.1177/17562864211058298. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 34899987 Free PMC article. Review.
41 results